Provision of free alemtuzumab (anti-CD52) to patients with chronic lymphocytic leukemia refractory to conventional chemotherapy

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Provision of free alemtuzumab (anti-CD52) to patients with chronic lymphocytic leukemia refractory to conventional chemotherapy
Principal Investigator
Professor Leung, Anskar Yu Hung   (Principal Investigator (PI))
Co-Investigator(s)
Professor Kwong Yok Lam   (Co-Investigator)
Duration
32
Start Date
2007-11-01
Amount
611288
Conference Title
Provision of free alemtuzumab (anti-CD52) to patients with chronic lymphocytic leukemia refractory to conventional chemotherapy
Presentation Title
Keywords
alemtuzumab, anti-CD52, chemotherapy, leukemia
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
207215
Grant Type
S.K. Yee Medical Foundation - General Award
Funding Year
2007
Status
Completed
Objectives
To provide free alemtuzumab for the treatment of refractory CLL to patients cannot afford this drug; to impove microbiological surveillance against fungal infection among patients who receive this drug.